Top consulting firm hid opioid conflicts of interest from the FDA, says Congressional report

More widespread testing may lead to earlier identification of COVID-19-positive individuals, further dampening the transmission of the disease and allowing for early treatment to improve outcomes, thus reducing the burden on the healthcare system. Our analysis suggests that global investment in COVID-19 vaccines to date has totaled at least $6.7 billion. Adam Feuerstein, ‚ÄúSinovac says…